AI-Powered test aims to match cancer patients with best drugs
Diagnosis
Not yet recruiting
This study is testing a new diagnostic tool called µCAN for people with advanced colorectal cancer that has spread. The test analyzes a small sample of a patient's tumor in a lab, using machine learning to screen how it reacts to different drugs. The goal is to give doctors a per…
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC